Search

everythinglearnresearchcommunity

for

Search:↓

A young Saudi girl with uncontrolled type 1 diabetes and hypothyroidism had two rare conditions, Mauriac syndrome and Van Wyk–Grumbach syndrome.

Thyroid function may influence hair loss after COVID-19.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Hair loss from mood stabilizers can grow back, but the reasons why are not fully understood.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

Infant skin cells may be less capable of repairing UV-induced DNA damage than adult cells.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Trichoscopy is useful for diagnosing Frontal Fibrosing Alopecia.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

Stress-related hair loss was reversed with a special medication.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Dermoscopy greatly improves melanoma diagnosis and reduces unneeded surgeries.

Early surgical intervention and a multidisciplinary approach are crucial for managing complex cardio-obstetric patients.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.